Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA: Cancer J Clin 72(1):7–33
Tian Y, Lai T, Li Z, Mao M, Jin Y, Liu Y, Guo R (2023) Role of non-coding RNA intertwined with the Wnt/β-catenin signaling pathway in endometrial cancer. Mol Med Rep 28(2):1–9
Albores-Saavedra J, Martinez-Benitez B, Luevano E (2008) Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: polypoid tumors and those arising in polyps may have a favorable prognosis. Int J Gynecol Pathol 27(3):333–339
Virarkar M, Vulasala SS, Morani AC, Waters R, Gopireddy DR, Kumar S, Bhosale P, Lall C (2022) Neuroendocrine neoplasms of the gynecologic tract. Cancers 14(7):1835
Article PubMed PubMed Central Google Scholar
Gibbs J, Mei S, Economos K, Lee YC, Kanis MJ (2019) Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis. Am J Obstet Gynecol 221(1):53-e1
Pocrnich CE, Ramalingam P, Euscher ED, Malpica A (2016) Neuroendocrine carcinoma of the endometrium: a clinicopathologic study of 25 cases. Am J Surg Pathol 40(5):577
Article PubMed PubMed Central Google Scholar
Parkash V, Aisagbonhi O, Riddle N, Siddon A, Panse G, Fadare O (2023) Recent advances in the classification of gynecological tract tumors: updates from the 5th edition of the World Health Organization “Blue Book”. Arch Pathol Lab Med. https://doi.org/10.5858/arpa.2022-0166-RA
Chetty R, Clark SP, Bhathal PS (1993) Carcinoid tumour of the uterine corpus. Virchows Archiv A 422:93–5
Hong SR, Kim HS, Shim JU (2004) primary carcinoid tumor of the uterine corpus: a case report. J Pathol Transl Med 38(2):109–12
Schlechtweg K, Chen L, Clair CM, Tergas AI, Khoury-Collado F, Hou JY, Melamed A, Neugut AI, Hershman DL, Wright JD (2019) Neuroendocrine carcinoma of the endometrium: disease course, treatment, and outcomes. Gynecol Oncol 155(2):254–61
Huntsman DG, Clement PB, Gilks CB, Scully RE (1994) Small-cell carcinoma of the endometrium. Am J Surg Pathol 18(4):364–75
Li J, Ouyang Y, Tao Y, Wang L, Li M, Gao L, Cao X (2020) Small cell carcinoma of the uterine cervix: a multi-institutional experience. Int J Gynecol Cancer 30(2). https://doi.org/10.1136/ijgc-2019-000612
Üreyen I, Karalok A, Turan T, Boran N, Tapısız ÖL, Ökten H, Kose MF, Tulunay G (2013) Small cell carcinoma of the endometrium: a report of three cases. J Turk Ger Gynecol Assoc 14(2):113
Article PubMed PubMed Central Google Scholar
Malpica A (2016) How to approach the many faces of endometrioid carcinoma. Mod Pathol 1(29):S29-44
Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K (2019) High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol 38(1 Suppl 1):S40
Mechtersheimer G, Staudter M, Möller P (1991) Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Can Res 51(4):1300–7
Garin-Chesa P, Fellinger EJ, Huvos AG, Beresford HR, Melamed MR, Triche TJ, Rettig WJ (1991) Immunohistochemical analysis of neural cell adhesion molecules. Differential expression in small round cell tumors of childhood and adolescence. Am J Pathol 139(2):275
PubMed PubMed Central Google Scholar
Miettinen M, Cupo W (1993) Neural cell adhesion molecule distribution in soft tissue tumors. Hum Pathol 24(1):62–6
Rooper LM, Sharma R, Li QK, Illei PB, Westra WH (2017) INSM1 demonstrates superior performance to the individual and combined use of synaptophysin, chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity. Am J Surg Pathol 41(11):1561–9
Zhang Q, Huang J, He Y, Cao R, Shu J (2021) Insulinoma-associated protein 1 (INSM1) is a superior marker for the diagnosis of gastroenteropancreatic neuroendoerine neoplasms: a meta-analysis. Endocrine 74(1):61–71
Kuji S, Endo A, Kubota M, Uekawa A, Kawakami F, Mikami Y, Koike J, Suzuki N (2023) Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix. J Gynecol Oncol 34(1). https://doi.org/10.3802/jgo.2023.34.e1
Giordano G, Ferioli E, Guareschi D, Tafuni A (2023) Dedifferentiated endometrial carcinoma: a rare aggressive neoplasm-clinical, morphological and immunohistochemical features. Cancers 15(21):5155
Article PubMed PubMed Central Google Scholar
Zhou F, Zhang X, Chen H, Zheng W (2020) Dedifferentiated endometrioid carcinomas with neuroendocrine differentiation: a clinicopathological and immunohistochemical study of three cases. Cancer Manag Res 13:11623–9
Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA (2010) Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol 23(6):781–9
Bartosch C, Lopes JM, Oliva E (2011) Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features. Adv Anat Pathol 18(6):415–37
Melgoza F, Brewster WR, Wilczynski S et al (2006) p16-Positive small cell neuroendocrine carcinoma of the endometrium. Int J Gynecol Pathol 25:252–6
Broaddus RR, Lynch HT, Chen LM, Daniels MS, Conrad P, Munsell MF, White KG, Luthra R, Lu KH (2006) Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer 106(1):87–94
Machado I, Navarro S, López-Guerrero JA, Verdini L, Picci P, Giner F, Llombart-Bosch A (2021) Neuroendocrine differentiation in a large series of genetically-confirmed Ewing’s sarcoma family tumor: does it provide any diagnostic or prognostic information? Pathol-Res Pract 1(219):153362
Pelosi G, Fraggetta F, Sonzogni A, Fazio N, Cavallon A, Viale G (2000) CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours. Virchows Arch 437:270–4
Russell-Goldman E, Hornick JL, Qian X, Jo VY (2018) NKX2. 2 immunohistochemistry in the distinction of Ewing sarcoma from cytomorphologic mimics: diagnostic utility and pitfalls. Cancer Cytopathology 126(11):942–9
Yoshida A (2023) Ewing and Ewing-like sarcomas: a morphological guide through genetically-defined entities. Pathol Int 73(1):12–26
Mulvany NJ, Allen DG (2008) Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium. Int J Gynecol Pathol 27(1):49–57
Deodhar KK, Kerkar RA, Suryawanshi P, Menon H, Menon S (2011) Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts. J Cancer Res Ther 7(2):211–3
Makihara N, Maeda T, Nishimura M, Deguchi M, Sonoyama A, Nakabayashi K, Kawakami F, Itoh T, Yamada H (2012) Large cell neuroendocrine carcinoma originating from the uterine endometrium: a report on magnetic resonance features of 2 cases with very rare and aggressive tumor. Rare Tumors 4(3):118–21
Terada T (2010) Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA. Pathol-Res Pract 206(6):420–5
Shahabi S, Pellicciotta I, Hou J, Graceffa S, Huang GS, Samuelson RN, Goldberg GL (2011) Clinical utility of chromogranin A and octreotide in large cell neuro endocrine carcinoma of the uterine corpus. Rare Tumors 3(4):129–31
Atienza-Amores M, Guerini-Rocco E, Soslow RA, Park KJ, Weigelt B (2014) Small cell carcinoma of the gynecologic tract: a multifaceted spectrum of lesions. Gynecol Oncol 134(2):410–8
Matsumoto H, Shimokawa M, Nasu K, Shikama A, Shiozaki T, Futagami M, Kai K, Nagano H, Mori T, Yano M, Sugino N (2019) Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan. J Gynecol Oncol 30(6). https://doi.org/10.3802/jgo.2019.30.e103
Sawada M, Matsuzaki S, Yoshino K, Ueda Y, Yoshida S, Kimura T, Ogita K (2016) Long-term survival in small-cell carcinoma of the endometrium with liver and brain metastases. Anticancer Drugs 27(2):138–43
留言 (0)